Cargando…
COVID-19 in Cladribine-treated patient with multiple sclerosis
Case report describing a patient infected with COVID-19 after initiation of Cladribine, with a favorable disease course and positive seroconversion.
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Published by Elsevier B.V.
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8349393/ https://www.ncbi.nlm.nih.gov/pubmed/34390951 http://dx.doi.org/10.1016/j.jneuroim.2021.577690 |
| _version_ | 1783735555967680512 |
|---|---|
| author | Haham, Nitsan Vaknin-Dembinsky, Adi |
| author_facet | Haham, Nitsan Vaknin-Dembinsky, Adi |
| author_sort | Haham, Nitsan |
| collection | PubMed |
| description | Case report describing a patient infected with COVID-19 after initiation of Cladribine, with a favorable disease course and positive seroconversion. |
| format | Online Article Text |
| id | pubmed-8349393 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | Published by Elsevier B.V. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-83493932021-08-09 COVID-19 in Cladribine-treated patient with multiple sclerosis Haham, Nitsan Vaknin-Dembinsky, Adi J Neuroimmunol Short Communication Case report describing a patient infected with COVID-19 after initiation of Cladribine, with a favorable disease course and positive seroconversion. Published by Elsevier B.V. 2021-10-15 2021-08-08 /pmc/articles/PMC8349393/ /pubmed/34390951 http://dx.doi.org/10.1016/j.jneuroim.2021.577690 Text en © 2021 Published by Elsevier B.V. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Short Communication Haham, Nitsan Vaknin-Dembinsky, Adi COVID-19 in Cladribine-treated patient with multiple sclerosis |
| title | COVID-19 in Cladribine-treated patient with multiple sclerosis |
| title_full | COVID-19 in Cladribine-treated patient with multiple sclerosis |
| title_fullStr | COVID-19 in Cladribine-treated patient with multiple sclerosis |
| title_full_unstemmed | COVID-19 in Cladribine-treated patient with multiple sclerosis |
| title_short | COVID-19 in Cladribine-treated patient with multiple sclerosis |
| title_sort | covid-19 in cladribine-treated patient with multiple sclerosis |
| topic | Short Communication |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8349393/ https://www.ncbi.nlm.nih.gov/pubmed/34390951 http://dx.doi.org/10.1016/j.jneuroim.2021.577690 |
| work_keys_str_mv | AT hahamnitsan covid19incladribinetreatedpatientwithmultiplesclerosis AT vaknindembinskyadi covid19incladribinetreatedpatientwithmultiplesclerosis |